Form 4: Elanco CEO Acquires Deferred Stock Units

Elanco Animal Health CEO Jeffrey N. Simmons acquired 113.4934 deferred stock units, increasing his beneficial ownership to 18,959.0151 units.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN), acquired deferred stock units on January 23, 2026.
• The transaction involved the acquisition of 113.4934 deferred stock units (DSUs).
• Each DSU represents the right to receive one share of company common stock or its cash equivalent.
• The DSUs were acquired at a price of $24.4 per unit.
• Following this transaction, Simmons beneficially owns 18,959.0151 deferred stock units.
• These DSUs settle in cash or shares of common stock upon termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: An insider acquisition, especially by the CEO, generally indicates confidence in the company's future, aligning management's interests with shareholders.

Positives

• CEO Jeffrey N. Simmons increased his beneficial ownership in the company by acquiring 113.4934 deferred stock units.
• This acquisition demonstrates continued alignment of management's interests with shareholders.

Future Outlook

Deferred stock units are scheduled to settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Industry Context

NA

Stakeholder Impact

• Shareholders may view the CEO's increased beneficial ownership as a positive sign of management's commitment and belief in the company's long-term prospects.

Next Steps

• Settlement of deferred stock units in cash or shares of common stock following termination of employment or during a specified future year.

Key Dates

Recommendation

While the CEO's acquisition of deferred stock units is a positive signal of confidence and aligns management's interests with shareholders, this routine compensation-related transaction alone is not typically a strong enough catalyst to warrant a 'buy' recommendation. It reinforces a 'hold' position for existing investors, indicating stable management commitment.

Keywords

Elanco, ELAN, Jeffrey N. Simmons, CEO, Director, Deferred Stock Units, DSU, Insider Trading, Stock Acquisition, Executive Compensation, Animal Health